The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis.
Authors: van Hylckama Vlieg MAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Nasserinejad K; Department of Haematology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.; Innovative Statistical Consulting, Therapeutics Development Team, Cytel Inc., Massachusetts, USA., Visser C; Department of Haematology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Bramer WM; Medical Library, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Ashrani AA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Bosson JL; Department of Public Health, Grenoble-Alpes University Hospital and TIMC-IMAG, Grenoble, France., Crusan DJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., D'Alessio A; Department of Medical Oncology and Internal Medicine, Policlinico San Marco, Istituti Ospedalieri Bergamaschi, Bergamo, Italy., Fluharty ME; Thrombosis Research Institute, London, United Kingdom., Ģībietis V; Department of Internal Diseases, Riga Stradiņš University, Riga, Latvia., Hansson PO; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, Geriatrics and Emergency Medicine, Sahlgrenska University Hospital/Östra, Gothenburg, Region Västra Götaland, Sweden., Hara N; Department of Cardiology, IMS Katsushika Heart Center, Tokyo, Japan., Jara-Palomares L; Medical Surgical Unit of Respiratory Diseases, Hospital Universitario Virgen del Rocío, Seville, Spain.; CIBERES, ISCIII, Madrid, Spain., Kraaijpoel N; Department of Vascular Medicine, Amsterdam UMC/University of Amsterdam, Amsterdam, the Netherlands., Mahé I; Université Paris Cité, Hôpital Louis Mourier, Assistance Publique des Hôpitaux de Paris, INSERM, UMR_ S1140 Innovative Therapies in Haemostasis, Paris, France., Marshall A; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK., Ogino Y; Department of Cardiology, Yokohama City University Medical Center, Yokohama, Japan., Otero R; Medical Surgical Unit of Respiratory Diseases, Hospital Universitario Virgen del Rocío, Seville, Spain.; CIBERES, ISCIII, Madrid, Spain., Versmissen J; Division of Vascular Medicine and Pharmacology, Department of Internal Medicine and Department of Hospital Pharmacy, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., Klok FA; Department of Medicine - Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands., Kruip MJHA; Department of Haematology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands., van der Rijt CCD; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Geijteman ECT; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Source: EClinicalMedicine [EClinicalMedicine] 2023 Sep 08; Vol. 64, pp. 102194. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2023.102194